StepStone Group Portfolio holdings
StepStone Group is a private markets firm that builds customized investment portfolios, monitors them and advises investors. Its business spans primary and secondary fund investments plus co-investments, across private equity, real estate, infrastructure, real assets and private debt. Its founders, Monte Brem and Thomas Keck, had earlier made private equity investments at Pacific Corporate Group, as president and managing director respectively. StepStone went public on the Nasdaq in September 2020. The firm serves institutional investors and sponsors worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veeva Systems
VEEV
|
+$2.82M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$158K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NovoCure
NVCR
|
+$5.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 53.21% |
| 2 | Healthcare | 28.04% |
| 3 | Industrials | 18.62% |
| 4 | Technology | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ATH
1
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $69M | 50.74% |
1,442,640
| – | – |
2017 Q2
3 quarters
|
|
|
2
NovoCure
NVCR
$1.37B
| $29.8M | 21.9% |
1,365,479
-250,000
| -15% | -$5.38M |
2016 Q1
8 quarters
|
|
|
FDC
3
DELISTED
First Data Corporation
FDC
| $25.3M | 18.62% |
1,581,821
| – | – |
2016 Q2
7 quarters
|
|
4
DELISTED
Asensus Surgical, Inc.
ASXC
| $5.16M | 3.79% |
233,279
| – | – |
2014 Q2
15 quarters
|
|
5
Fidus Investment
FDUS
$780M
| $3.35M | 2.46% |
260,105
| – | – |
2013 Q2
19 quarters
|
|
|
6
Veeva Systems
VEEV
$49.3B
| $3.19M | 2.34% |
+43,634
| New | +$2.82M |
2018 Q1
0 quarters
|
|
|
COUP
7
DELISTED
Coupa Software Incorporated
COUP
| $186K | 0.14% |
+3,844
| New | +$158K |
2018 Q1
0 quarters
|
|
Similar funds
StepStone Group's Q1 2018 Portfolio in Review
As of Q1 2018, StepStone Group held 7 positions worth $136M, down 5.3% from $143M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
StepStone Group's Q1 2018 filing shows 2 new and 1 reduced positions. Its largest new stake was Veeva Systems: 43,634 shares worth $3.19M. The largest sale was NovoCure, an estimated $5.38M.
By sector, the portfolio is most concentrated in Financials at 53% of assets, down from 55% a quarter earlier, followed by Healthcare and Industrials.
- StepStone Group's largest Q1 2018 buy was Veeva Systems: 43,634 shares worth $3.19M.
- StepStone Group's biggest Q1 2018 reduction was NovoCure, cutting an estimated $5.38M.
- StepStone Group's ten largest holdings make up 100% of its $136M portfolio in Q1 2018.
- StepStone Group opened 2 new positions and closed 0 in Q1 2018.
- StepStone Group's portfolio value fell 5.3% quarter-over-quarter to $136M.
Based on StepStone Group's 13F filing for Q1 2018, filed 15 May 2018.